InvestorsHub Logo
Followers 0
Posts 2465
Boards Moderated 0
Alias Born 06/03/2011

Re: gumibear post# 4

Saturday, 11/08/2014 9:03:43 PM

Saturday, November 08, 2014 9:03:43 PM

Post# of 140
Sorry to hear that gumi , you didn't specify as to whether or not you sold for a loss or are still holding and down $9K. Not for nothing , this company is very new to the market and still has an $8.50 and $9.00 price target w/ a neutral rating.. I dont see this going much lower but who know's. GL

Roka Bioscience (NASDAQ:ROKA) was downgraded by Wedbush from an “outperform” rating to a “neutral” rating in a research note issued on Friday, TheFlyOnTheWall.com reports. They currently have a $9.00 target price on the stock, down from their previous target price of $15.00.
A number of firms have recently commented on ROKA. Analysts at Bank of America downgraded shares of Roka Bioscience from a “buy” rating to a “neutral” rating in a research note on Friday. They now have a $8.50 price target on the stock, down previously from $14.00. Finally, analysts at Cowen and Company initiated coverage on shares of Roka Bioscience in a research note on Monday, August 11th. They set an “outperform” rating and a $13.00 price target on the stock.
Shares of Roka Bioscience (NASDAQ:ROKA) opened at 3.00 on Friday. Roka Bioscience has a 52 week low of $2.97 and a 52 week high of $13.00. The stock has a 50-day moving average of $9.36 and a 200-day moving average of $10.30. The company’s market cap is $53.0 million.